PRESEPSIN Trademark

Trademark Overview

On Wednesday, December 14, 2011, a trademark application was filed for PRESEPSIN with the United States Patent and Trademark Office. The USPTO has given the PRESEPSIN trademark a serial number of 85495648. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 11, 2020. This trademark is owned by Mochida Pharmaceutical Co., Ltd.. The PRESEPSIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the diagnosis and treatment of sepsis and bacterial infection
presepsin

General Information

Serial Number85495648
Word MarkPRESEPSIN
Filing DateWednesday, December 14, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 11, 2020
Registration Number4526194
Registration DateTuesday, May 6, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 18, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the diagnosis and treatment of sepsis and bacterial infection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 11, 2020
Primary Code005
First Use Anywhere DateTuesday, December 31, 2013
First Use In Commerce DateTuesday, December 31, 2013

Trademark Owner History

Party NameMochida Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 160-0004
JP
Party NameMochida Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 160-0004
JP
Party NameMochida Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 160-0004
JP

Trademark Events

Event DateEvent Description
Friday, December 11, 2020CANCELLED SEC. 8 (6-YR)
Monday, May 6, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 6, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, April 2, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 1, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Sunday, March 30, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 13, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, February 7, 2014USE AMENDMENT FILED
Sunday, March 2, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 7, 2014TEAS STATEMENT OF USE RECEIVED
Saturday, August 3, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2013EXTENSION 1 GRANTED
Thursday, August 1, 2013EXTENSION 1 FILED
Thursday, August 1, 2013TEAS EXTENSION RECEIVED
Tuesday, February 12, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 18, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 28, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 15, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 13, 2012ASSIGNED TO LIE
Monday, October 29, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 25, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 25, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 25, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 29, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 29, 2012NON-FINAL ACTION E-MAILED
Thursday, March 29, 2012NON-FINAL ACTION WRITTEN
Thursday, March 22, 2012ASSIGNED TO EXAMINER
Thursday, December 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 17, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

presepsin bacterial infection sepsis treatment preparations diagnosis pharmaceutical